Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Analyst Yu Jin: Suspects Astra Nova theft, as fund flows do not match typical hacker behavior

Analyst Yu Jin: Suspects Astra Nova theft, as fund flows do not match typical hacker behavior

ChaincatcherChaincatcher2025/10/19 03:38
Show original

ChainCatcher reported that individuals have expressed doubts about the claim that "Astra Nova (RVV) had its third-party managed account stolen." The hacker converted the stolen assets into USDT and transferred them directly to a CEX, which is unusual. USDT can be frozen, and transferring directly to a CEX may trigger risk controls; hackers generally do not operate this way.

Currently, a total of 860 million RVV (8.6% of the total supply) was transferred from the project's minting contract and sold on-chain, causing a sharp drop in RVV. The sale of 860 million RVV yielded 10.288 million USDT, of which 8.226 million USDT was transferred into CEXs, while another 2.041 million USDT remains in the on-chain wallet 0x643. Previously, Astra Nova stated that a third-party market-making account was compromised, allowing the attacker to control the assets and begin liquidation.

.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.

TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).

智通财经2026/09/21 07:11